PrEP drug reduces risk of HIV by 90%'

SOWETO, SOUTH AFRICA NOVEMBER 30:(SOUTH AFRICA OUT): Thembelani Sibanda shows the Pre-Exposure Prophylaxis (PrEP), an HIV preventative drug during an interview on November 30, 2017 in Soweto, South Africa. Sibanda, who is not HIV-positive, takes a preventative drug due to his lifestyle that he feels puts him at risk of contracting the virus. (Photo by Daniel Born/The Times/Gallo Images/Getty Images)
SOWETO, SOUTH AFRICA NOVEMBER 30:(SOUTH AFRICA OUT): Thembelani Sibanda shows the Pre-Exposure Prophylaxis (PrEP), an HIV preventative drug during an interview on November 30, 2017 in Soweto, South Africa. Sibanda, who is not HIV-positive, takes a preventative drug due to his lifestyle that he feels puts him at risk of contracting the virus. (Photo by Daniel Born/The Times/Gallo Images/Getty Images)
PrEP drug reduces risk of HIV by 90%'
EINE LIZENZ KAUFEN
Wie darf ich dieses Bild verwenden?
475,00 €
EUR

DETAILS

Einschränkungen:
Bei kommerzieller Verwendung sowie für verkaufsfördernde Zwecke kontaktieren Sie bitte Ihr lokales Büro.SOUTH AFRICA OUT
Bildnachweis:
The Times / Kontributor
Redaktionell #:
888296568
Kollektion:
Gallo Images
Erstellt am:
1. Dezember 2017
Hochgeladen am:
Lizenztyp:
Lizenzpflichtig
Releaseangaben:
Kein Release verfügbar. Weitere Informationen
Quelle:
Gallo Images Editorial
Objektname:
AV_00070642
Max. Dateigröße:
3543 x 2362 px (30,00 x 20,00 cm) - 300 dpi - 3 MB